Ticker Details
Alumis Inc. Common Stock
IPO Date:	June 28, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 4.25%
Avg Daily Range (30 D):	$0.96 | 3.94%
Avg Daily Range (90 D):	$0.59 | 4.19%

Institutional Daily Volume
Avg Daily Volume:	.78M
Avg Daily Volume (30 D):	1.82M
Avg Daily Volume (90 D):	2.11M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	89
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	242
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$1.61M
Avg Institutional Trade (90 D):	$1.51M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.66M
Avg Closing Trade (30 D):	$3.35M
Avg Closing Trade (90 D):	$2.58M
Avg Closing Volume:	189.73K

News

Jan 8, 2026 @ 3:52 AM Alumis Announces Pricing of Upsized Public Offerin... Source: Na

Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith

Jan 5, 2026 @ 10:00 PM Alumis to Host Conference Call and Webcast to Repo... Source: Na

Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight

Aug 13, 2025 @ 8:28 PM Alumis Misses Q2 Revenue as Costs Jump Source: Na

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.15	$-1.06
Diluted EPS	$-2.15	$-1.06
Revenue	$22.12M	$2.07M
Gross Profit
Net Income / Loss	$-245.15M	$-110.75M	$59.32M
Operating Income / Loss	$-455.98M	$-115.29M
Cost of Revenue
Net Cash Flow	$-147.81M
PE Ratio